Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Chantal Reusken
National Institute for Public Health and the Environment (RIVM) - WHO Reference Laboratory for COVID-19
Bilthoven
Netherlands
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
286
TOTAL CITATIONS
0
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Elevated Nucleoprotein-Induced Interferon-γ Release in COVID-19 Patients Detected in a SARS-CoV-2 Enzyme-Linked Immunosorbent Spot Assay
Number of pages: 22
Posted: 23 Jun 2020
Steven Thijsen
,
Michiel Heron
,
Hendrik Gremmels
,
Robert van der Kieft
, Chantal Reusken,
Kristin Kremer
,
Gijs Limonard
and
Ailko Bossink
Diakonessen Hospital - Department of Medical Microbiology & Immunology, Diakonessen Hospital - Department of Medical Microbiology & Immunology, Diakonessen Hospital - Department of Medical Microbiology & Immunology, Diakonessen Hospital - Department of Medical Microbiology & Immunology, National Institute for Public Health and the Environment (RIVM) - WHO Reference Laboratory for COVID-19, National Institute for Public Health and the Environment (RIVM) - WHO Reference Laboratory for COVID-19, Diakonessen Hospital - Department of Pulmonary Diseases and Diakonessen Hospital - Department of Pulmonary Diseases
Downloads
145
(511,933)
View PDF
Download
Abstract:
SARS-CoV-2; COVID-19; interferon-gamma release assay; ELISpot; T-cell response
2.
Serological Evidence for Reinfection with SARS-CoV-2; An Observational Cohort Study
Number of pages: 17
Posted: 08 Mar 2021
Robert Samuel van Binnendijk
,
Gerco den Hartog
,
Johan Reimerink
,
Rutger Schepp
,
Sabiena Feenstra
,
Daphne Reukers
, Chantal Reusken,
Dirk Eggink
,
Elisabeth A.M. Sanders
,
Titia Kortbeek
and
Harry Vennema
National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM) - WHO Reference Laboratory for COVID-19, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) and National Institute for Public Health and the Environment (RIVM)
Downloads
141
(537,489)
View PDF
Download
Abstract:
Feedback